NEXILIS AG is a Swiss MedTech company founded in 2005. The company's slogan "Revolutionizing implant fixation" reflects its progressive technology that aims to improve implant stabilization, particularly in patients with poor bone quality. The NEXILIS immediate stabilization system (ISS) enhances the anchorage of fixation screws in bone, leading to a significantly improved interface between screws and surrounding bone. This innovation is crucial for a safe healing process and durable treatment effect.
NEXILIS operates in the Biotechnology and Manufacturing industries, with its headquarters located in Switzerland. Although specific details about its last investment and investors are not available at the moment, the company's focus on addressing a critical issue in the medical field and its innovative approach make it an intriguing prospect for potential investors.
There is no investment information
No recent news or press coverage available for NEXILIS AG.